Wilkerson Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46K Buy
119
+48
+68% +$17.8K 0.01% 240
2026
Q1
$20.8K Buy
71
+9
+15% +$2.96K 0.01% 299
2025
Q4
$21.7K Buy
+62
New +$21K 0.01% 231

Other funds holding ELV

Wilkerson Advisory Group's ELV Position: Q2 2026 in Review

Wilkerson Advisory Group increased its Elevance Health (ELV) stake by 68% in Q2 2026, buying an estimated $17.8K and bringing the position to 119 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #240.

Wilkerson Advisory Group first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wilkerson Advisory Group held 119 shares of Elevance Health worth $46K as of Q2 2026.
  • Wilkerson Advisory Group bought 48 Elevance Health shares in Q2 2026, an estimated $17.8K.
  • Elevance Health made up 0.01% of Wilkerson Advisory Group's portfolio in Q2 2026, its #240 holding.
  • Wilkerson Advisory Group first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.